Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Tunis Med ; 98(1): 17-21, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-32395773

RESUMO

INTRODUCTION: Although the use of Reference Management Software (RMS) is increasing in developed countries, they seem to be unknown and less used in low-income countries. AIM: To discover the major trends in the use of RMS among researchers and Ph.D. students in Tunisia, as a low-income country. METHODS: A hardcopy survey was filled out by researchers and Ph.D. students during an educational seminar at the faculty of medicine of Sfax in 2016 with the aim to collect qualitative data to determine the participants' knowledge and use of RMS. RESULTS: The survey collected 121 participants, among them, 53.7% know RMS. Mendeley proved to be the best-known software (41.5%), followed by Zotero (35.3%) and Endnote (23%). Training sessions in RMS were taken by 5% of participants. Among the 121 participants, 26.5%of them use RMS., Mendeley was the most used (46.9%), followed by EndNote (28.1%) and Zotero (25%). The most commonly popular feature in RMS is inserting citations (66.9%). Therefore, the analysis, of the reasons behind the choice of RMS proves that the software was used because it is convenient (38.4%),  most known (38.4%),  easy (30.7%), or suggested by colleagues (30.7%). The free and open-source software was preferred by 81% of the participants. g. However, 50.4% ignore the fact that Zotero is free. Several types and sources of captured citations were unknown by 53.8% and 59% of the rest of the participants. CONCLUSION: The results clearly show that the lack of awareness about RMS in Tunisia is due to the absence of a formal training. As a result, the need for such training is highly important for researchers to be able to benefit from the different advantages of RMS while conducting their academic medical education.


Assuntos
Bases de Dados Factuais , Conhecimentos, Atitudes e Prática em Saúde , Gestão da Informação , Pessoal de Laboratório/estatística & dados numéricos , Publicações Seriadas/provisão & distribuição , Software , Estudantes de Medicina/estatística & dados numéricos , Acesso à Informação , Bases de Dados Factuais/economia , Bases de Dados Factuais/normas , Bases de Dados Factuais/provisão & distribuição , Educação Médica/economia , Educação Médica/normas , Humanos , Gestão da Informação/economia , Gestão da Informação/educação , Gestão da Informação/métodos , Gestão da Informação/normas , Pessoal de Laboratório/economia , Pobreza/estatística & dados numéricos , Publicações Seriadas/economia , Publicações Seriadas/normas , Software/economia , Inquéritos e Questionários , Tunísia/epidemiologia
3.
Tunis Med ; 94(10): 604-611, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28972252

RESUMO

BACKGROUND: Tuberculosis (TB) infects one third of the world population. Its economic impact is important, affecting the global economy in the World. OBJECTIVE: To determine the economic costs related to tuberculosis in Tunisia. METHODS: Calculations were made for the reference year 2013; we covered all cost components of the disease, which are related to program management, BCG vaccination, health workers training, social mobilization, screening, chemoprophylaxis, and tuberculosis care. With the exception of costs related to care, which were the subject of a specific survey, the costs of other categories were obtained from the National TB Control Program. RESULTS: The cost of the different components related to the management, prevention, screening and tuberculosis care in 2013 amounted 504688,000DT. The cost of care represented 80.0% of total costs (6807 808,000DT) ; cost related to program  management represented 13.2% (1 121 580,00 DT) and the BCG vaccination  6.0% e (512 300,00DT) The average cost per patient was 1447,360 DTin 2013. CONCLUSION: Reducing the cost of tuberculosis, would involve reducing diagnostic delay. It is also recommended to reduce hospitalization recourse, and prevent multidrug resistance which lead to additional expenditures.


Assuntos
Efeitos Psicossociais da Doença , Tuberculose Pulmonar/economia , Adolescente , Adulto , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Antituberculosos/economia , Vacina BCG/economia , Criança , Pré-Escolar , Feminino , Pessoal de Saúde/educação , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Distribuição por Sexo , Tuberculose Pulmonar/diagnóstico , Tuberculose Pulmonar/epidemiologia , Tuberculose Pulmonar/prevenção & controle , Tunísia/epidemiologia , Vacinação/economia , Adulto Jovem
4.
Tunis Med ; 94(8-9): 604-611, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28685796

RESUMO

BACKGROUND: Tuberculosis (TB) infects one third of the world population. Its economic impact is important, affecting the global economy in the World. OBJECTIVE: To determine the economic costs related to tuberculosis in Tunisia. METHODS: Calculations were made for the reference year 2013; we covered all cost components of the disease, which are related to program management, BCG vaccination, health workers training, social mobilization, screening, chemoprophylaxis, and tuberculosis care. With the exception of costs related to care, which were the subject of a specific survey, the costs of other categories were obtained from the National TB Control Program. RESULTS: The cost of the different components related to the management, prevention, screening and tuberculosis care in 2013 amounted 504688,000DT. The cost of care represented 80.0% of total costs (6807 808,000DT) ; cost related to program  management represented 13.2% (1 121 580,00 DT) and the BCG vaccination  6.0% e (512 300,00DT) The average cost per patient was 1447,360 DTin 2013. CONCLUSION: Reducing the cost of tuberculosis, would involve reducing diagnostic delay. It is also recommended to reduce hospitalization recourse, and prevent multidrug resistance which lead to additional expenditures.


Assuntos
Custos e Análise de Custo , Tuberculose Pulmonar/economia , Diagnóstico Tardio , Humanos , Tuberculose Resistente a Múltiplos Medicamentos/economia , Tuberculose Resistente a Múltiplos Medicamentos/prevenção & controle , Tuberculose Pulmonar/diagnóstico , Tuberculose Pulmonar/terapia , Tunísia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA